Literature DB >> 7576016

Hepatitis C virus infection as a possible risk factor for ductopenic rejection (vanishing bile duct syndrome) after liver transplantation.

R M Hoffmann1, C Günther, H M Diepolder, R Zachoval, H J Eissner, H Forst, M Anthuber, G Paumgartner, G R Pape.   

Abstract

Irreversible ductopenic rejection (DR) after orthotopic liver transplantation (OLT) is a major cause of late hepatic allograft failure. A variety of risk factors for DR have been postulated, but they are controversial. All transplant recipients at our institution with graft survival of more than 1 month (n = 120) were examined retrospectively with a view to possible risk factors for DR. These factors included age, sex, underlying liver disease, hepatitis B and C infections, donor-recipient CMV status, post-OLT CMV infections, immunosuppressive regimen, ABO blood type, and HLA class I and class II mismatches. Statistical analysis was performed with the univariate chi-square test or the two-tailed Fischer's exact test. Ten patients (8.3%) developed DR. Seventeen patients had HCV infections after OLT. In this group, the incidence of DR was highest (4 of 17, or 23.5%). This was significantly higher than for all other OLT groups (6 of 103 patients, or 5.8%; P < 0.03). The other factors analyzed did not reach statistical significance, including those that other authors found important for the development of DR. It may well be that hepatitis C infection predisposes one to the development of DR after OLT.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576016     DOI: 10.1007/BF00337166

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  5 in total

1.  Hepatitis C and bile duct loss.

Authors:  R D Goldin; N K Patel; H C Thomas
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

2.  Vanishing Bile Duct Syndrome in an Adult Patient: Case Report and Review of the Literature.

Authors:  Paolo Izzo; Gaetano Gallo; Massimo Codacci Pisanelli; Giuliano D'Onghia; Leonardo Macci; Raimondo Gabriele; Andrea Polistena; Luciano Izzo; Sara Izzo; Luigi Basso
Journal:  J Clin Med       Date:  2022-06-07       Impact factor: 4.964

3.  Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases.

Authors:  Ana Paula Oppenheimer; Christopher Koh; Mary McLaughlin; John C Williamson; Thomas D Norton; Jennifer Laudadio; Theo Heller; David E Kleiner; Kevin P High; Caryn G Morse
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

Review 4.  Cytomegalovirus and chronic allograft rejection in liver transplantation.

Authors:  Liang-Hui Gao; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

5.  Acute vanishing bile duct syndrome after therapy with cephalosporin, metronidazole, and clotrimazole: A case report.

Authors:  Zonghao Zhao; Lei Bao; Xiaolan Yu; Chuanlong Zhu; Jing Xu; Yu Wang; Ming Yin; Yi Li; Wenting Li
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.